For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associ ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

[5] Dulaglutide: A type of glucagon-like peptide-1 (GLP-1) receptor agonist approved by the U.S. Food and Drug Administration ...

A mum is warning people not to take skinny jabs from 'strangers on the internet' - after nearly dying when she accidentally injected 'five times' the recommended dose sent as a 'freebie' over ...

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere ... I would rather take an injectable weight-loss drug, rather than make a diet change.” More than half (62%) disagreed, with ...

Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis.